Lupin Limited has informed the Exchange regarding a press release dated Jun 25, 2025, titled "Lupin Receives Approval from U.S. FDA for Prucalopride Tablets".
Lupin Limited has informed the Exchange regarding a press release dated Jun 25, 2025, titled "Lupin Receives Approval from U.S. FDA for Prucalopride Tablets".